Technical report on the toxicology and carcinogenesis studies of naphthalene (CAS no. 91-20-3) in B6C3F1 mice (inhalation studies)

HERO ID

67449

Reference Type

Technical Report

Subtype

NTP

Year

1992

Language

English

PMID

12621520

HERO ID 67449
Material Type NTP
Year 1992
Title Technical report on the toxicology and carcinogenesis studies of naphthalene (CAS no. 91-20-3) in B6C3F1 mice (inhalation studies)
Authoring Organization National Institutes of Health, Department of Health and Human Services
Publisher Text National Institute of Health
City Research Triangle Park, NC
Volume GRA and I
Abstract Naphthalene, a white, crystalline powder, is used as a moth repellent and in the manufacture of phthalic and anthranilic acids, naphthylamines, and synthetic resins. The 2-year studies were conducted by exposing groups of male and female B6C3F1 mice to naphthalene (>99% pure) vapor for 6 hours daily, 5 days per week, for 104 weeks. Genetic toxicology studies were conducted in Salmonella typhimurium and Chinese hamster ovary cells. 2-Year Studies: Groups of male and female mice were exposed to atmospheres containing 0 (75 mice per group), 10 (75 mice per group), or 30 ppm (150 mice per group) naphthalene. Mice from each group were included for 14-day hematology evaluations (male: 0 ppm, 5 animals; 10 ppm, 4; 30 ppm, 10; female: 0 ppm, 4; 10 ppm, 5; 30 ppm, 10). Mean body weights of exposed mice were slightly lower than those of controls throughout the studies. Survival of male control mice was significantly less than that of exposed mice; the lower survival was the result of wound trauma and secondary infections related to fighting among the group-housed mice (0 ppm, 26/70, 37%; 10 ppm, 52/69, 75%; 30 ppm, 118/133, 89%). Survival of exposed female mice was similar to that of controls (59/69, 86%; 57/65, 88%; 102/135, 76%). Neoplastic and Nonneoplastic Effects in the 2-Year Studies: No increase in tumor incidence related to naphthalene administration was observed in male mice. In females, the incidence of pulmonary alveolar/bronchiolar adenomas was significantly greater in the high-dose group than in the controls (5/69, 7%; 2/65, 3%; 28/135, 21%). One other high-dose female had an alveolar/bronchiolar carcinoma. The combined incidence of alveolar/ bronchiolar adenomas and carcinomas in the high-dose females was above those for control female B6C3F1 mice from NTP feed, water, and inhalation studies (91/1,166, 7.8%, range 0%-16%). These lung tumors were attributed to naphthalene exposure. Nonneoplastic lesions attributed to naphthalene exposure were observed in the nose and lungs of mice of both sexes. In the nose, naphthalene exposure was associated with an increase in the incidence and severity of chronic inflammation, metaplasia of the olfactory epithelium, and hyperplasia of respiratory epithelium. Chronic inflammation in the lung was associated with chemical exposure. Genetic Toxicology: Naphthalene was negative for the induction of gene mutations in Salmonella typhimurium strains TA100, TA1535, TA1537, and TA98 with and without exogenous metabolic activation (S9). In cytogenetic tests with Chinese hamster ovary cells, naphthalene induced sister chromatid exchanges with and without S9 activation. Exposure to naphthalene induced a significant increase in chromosomal aberrations in Chinese hamster ovary cells in the presence of S9. Conclusions: Under the conditions of these 2-year inhalation studies, there was no evidence of carcinogenic activity of naphthalene in male B6C3F1 mice exposed to 10 or 30 ppm. There was some evidence of carcinogenic activity of naphthalene in female B6C3F1 mice, based on increased incidences of pulmonary alveolar/ bronchiolar adenomas. In both male and female mice, naphthalene caused increased incidences and severity of chronic inflammation, metaplasia of the olfactory epithelium, and hyperplasia of the respiratory epithelium in the nose and chronic inflammation in the lungs. Synonyms: Naphthalin, Naphthene, Tar Camphor
Pmid 12621520
Report Number NTP TR 410; NIH Publication No. 92-3141
Ntis Number PB92224260
Url http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr410.pdf
Is Certified Translation No
Dupe Override No
Number Of Pages 172
Comments 1 in B6C3F1 in title is subscript.Washington, DC: U.S. Department of Health and Human Services, National Institutes of Health; NIH publication no. 92-3141. (NTP technical report series: no. 410).
Is Public Yes
Language Text English
Keyword <?xml version="1.0" encoding="UTF-8"?><kw>ANIMAL</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>acute toxicity</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>carcinogenicity</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>carcinogens</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>genetic toxicity</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>mutagens</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>toxicokinetics</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>respiratory system</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>eye</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>cardiovascular system</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>dose response</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>HUMAN</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>case report</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>occupational exposure</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>acute effect</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>nervous system</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>gastrointestinal system</kw>; <?xml version="1.0" encoding="UTF-8"?><kw>blood</kw>
Relationship(s)